Oklahoma · G0105

Colorectal Cancer Screening; Colonoscopy On Individual At High Risk in Oklahoma

Oklahoma Medicare Avg
$227.78
14% below national avg
National Medicare Avg
$265.12
All states combined
Billed Charge (OK)
$817.28
What providers submit
Est. Commercial (OK)
$489.72
National avg: $593.88
Est. Cash / Self-Pay (OK)
$395.58
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

4.3K
Services in OK
213
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Oklahoma

Provider Medicare Services
Gsi Asc, Llc $377.49 430
Tulsa Ok Endoscopy Asc Llc $369.73 329

Oklahoma Pricing in Context

In Oklahoma, CPT code G0105 (Colorectal Cancer Screening; Colonoscopy On Individual At High Risk) carries an average Medicare payment of $227.78 — 14% below the national benchmark of $265.12. 213 providers across the state submitted claims for this procedure in 2023, performing 4.3K total services. Individual payments in OK ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Oklahoma is $817.28, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Oklahoma sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Preventive Screening procedures, the estimated commercial insurance price in Oklahoma lands near $489.72, with self-pay cash prices typically around $395.58. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Colorectal Cancer Screening; Colonoscopy On Individual At High Risk cost in Oklahoma?

The average Medicare payment for Colorectal Cancer Screening; Colonoscopy On Individual At High Risk in Oklahoma is $227.78, which is 14% below the national average of $265.12. Providers in OK typically bill $817.28 for this procedure.

What does Colorectal Cancer Screening; Colonoscopy On Individual At High Risk cost with insurance in Oklahoma?

With commercial insurance in Oklahoma, Colorectal Cancer Screening; Colonoscopy On Individual At High Risk costs an estimated $489.72. Without insurance, the estimated cash price is $395.58. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Colorectal Cancer Screening; Colonoscopy On Individual At High Risk in Oklahoma?

213 providers in Oklahoma billed Medicare for Colorectal Cancer Screening; Colonoscopy On Individual At High Risk in 2023, performing 4.3K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Colorectal Cancer Screening; Colonoscopy On Individual At High Risk cheaper in Oklahoma than the national average?

Yes — Colorectal Cancer Screening; Colonoscopy On Individual At High Risk costs 14% below the national average in Oklahoma. The state average Medicare payment is $227.78 compared to $265.12 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial